Aspirin or Clopidogrel Following Dual Antiplatelet Therapy in PCI-Treated Acute Coronary Syndrome Patients: A Real-World Population-Based Study
Background: Recent guidelines on Chronic Coronary Syndromes, for long-term monotherapy after acute coronary syndrome (ACS) or revascularization, have upgraded the recommendation for clopidogrel to the same strength as aspirin. We aimed to evaluate temporal trends and predictors of aspirin use compared to clopidogrel mo...